v3.22.2.2

Condensed Balance Sheets - USD ($)	Sep. 30, 2022	Dec. 31, 2021
CURRENT ASSETS
Cash	$ 1,129,849	$ 1,541,231
Prepaid expenses and other current assets	380,608	658,308
Total current assets	1,510,457	2,199,539
Prepaid expenses - non current		202,948
Deferred tax asset		19,152
Investments held in Trust Account	118,580,072	117,876,981
TOTAL ASSETS	120,090,529	120,298,620
CURRENT LIABILITIES
Accounts payable and accrued expenses	348,344	27,011
Franchise tax payable	15,537	93,223
Income tax payable	96,670
Due to affiliate	53,000	10,000
Total current liabilities	513,551	130,234
Derivative warrant liabilities	817,500	4,741,500
Deferred underwriting fee payable	4,025,000	4,025,000
Total liabilities	5,356,051	8,896,734
COMMITMENTS AND CONTINGENCIES (Note 6)
REDEEMABLE COMMON STOCK
Class A common stock subject to possible redemption, $0.0001 par value, 11,500,000 shares at redemption value of $10.28 per share at September 30, 2022 and $10.25 per share at December 31, 2021	118,234,996	117,875,000
STOCKHOLDERS’ DEFICIT
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Class A common stock; $0.0001 par value; 100,000,000 shares authorized; none issued or outstanding (excluding 11,500,000 shares subject to possible redemption)
Class B common stock; $0.0001 par value; 10,000,000 shares authorized; 2,875,000 shares issued and outstanding	287	287
Additional paid-in capital
Accumulated deficit	(3,500,805)	(6,473,401)
Total stockholders’ deficit	(3,500,518)	(6,473,114)
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT	$ 120,090,529	$ 120,298,620

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

No definition available.

LAVA Medtech Acquisition Corp. 10-Q